Literature DB >> 26674659

Rare Neoplasia of the Stomach.

Christia Schulz1, Kersti Schütte1, Pete Malfertheiner1.   

Abstract

BACKGROUND: Gastric adenocarcinoma accounts for more than 90% of malignant lesions of the stomach. Besides this entity, numerous neoplastic lesions with malignant or benign characteristics as well as lesions with uncertain malignant potential occur. This review gives an overview on rare neoplasia of the stomach, focusing on gastric polyps, gastrointestinal stromal tumors, gastric lymphoma and neuroendocrine neoplasia.
SUMMARY: A broad spectrum of rare neoplastic lesions of the stomach with significant differences in malignant potential and with specific demands of interventional therapy is known. In addition to the use of high-definition endoscopy techniques, the histopathological assessment of lesions and of the surrounding mucosa is mandatory to characterize and differentiate malignant and benign tumors. KEY MESSAGE: Rare neoplasia of the stomach is detected in approximately 6% of patients undergoing esophagogastroduodenoscopy. Diligent examination of the gastric mucosa remains essential to detect mucosal and submucosal lesions. PRACTICAL IMPLICATIONS: Presenting with a broad spectrum of symptoms, ranging from unspecific abdominal discomfort to gastrointestinal bleeding or symptoms of gastric outlet obstruction, different rare neoplastic lesions of the stomach with demand of specific diagnostic and therapeutic work-up occur. Diligent endoscopic evaluation of the entire gastric mucosa, preferably by high-definition endoscopy techniques, is essential in addition to histopathological examination of lesional and surrounding tissue.

Entities:  

Keywords:  Gastric polyps; Gastrointestinal stromal tumor; Lymphoma of the stomach; Neuroendocrine tumors; Secondary neoplasia

Year:  2015        PMID: 26674659      PMCID: PMC4668797          DOI: 10.1159/000435899

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  34 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

2.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Well-differentiated gastric tumors/carcinomas.

Authors:  Philippe Ruszniewski; Gianfranco Delle Fave; Guillaume Cadiot; Paul Komminoth; Daniel Chung; Beata Kos-Kudla; Reza Kianmanesh; David Hochhauser; Rudolf Arnold; Hakan Ahlman; Stanislas Pauwels; Dik J Kwekkeboom; Guido Rindi
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

4.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

5.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

6.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

7.  Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.

Authors:  Stefano La Rosa; Frediano Inzani; Alessandro Vanoli; Catherine Klersy; Linda Dainese; Guido Rindi; Carlo Capella; Cesare Bordi; Enrico Solcia
Journal:  Hum Pathol       Date:  2011-05-04       Impact factor: 3.466

8.  [Neuroendocrine tumors of the stomach. Risk stratification and therapy].

Authors:  G Klöppel; H Scherübl
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

Review 9.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

Review 10.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

View more
  2 in total

1.  Well-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site.

Authors:  Burak Gumuscu; Kevin Norwood; George A Parker; C Lee Bridges; Carl B Rountree
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors.

Authors:  Jun-Ming Luo; Fa-Long Cao; Chen Meng; Li-Jun Lin; Si-Qing Ma; Shao-Hua Peng; Hong-Ling Gao; Sara Javidiparsijani; Gui-Rong Wang; Meng-Lan Zhang; Jian-Guo Xin; Yi-Chun Wang; Shu-Kun Zhang
Journal:  Sci Rep       Date:  2017-10-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.